Julia Hepp, Ph.D., is Vice President, Partnering & Alliances at Molecular Partners. Julia brings two decades of biotech experience in research and development, alliance management and business development to the team. Julia joined Molecular Partners in its early days of pioneering the DARPin technology and is now responsible of the full value chain of business development from partnering, transactions to alliance management. Prior to joining Molecular Partners Julia was Director Project Management at Vivendy Therapeutics and headed Antibody Development at Micromet AG (acquired by Amgen). She obtained her Ph.D. from the Cambridge Centre for Protein Engineering with Sir A. Fersht and did postdoctoral research at University of Zurich in the Lab of Prof Plückthun, already working on the DARPin technology.